Amwell® Announces Results for Fourth Quarter and Full Year 2024
Amwell (NYSE: AMWL), a provider of SaaS-based technology-enabled healthcare platform, has announced its financial results for the fourth quarter and full year 2024. The company will discuss these results during a conference call scheduled for February 12, 2025, at 5 p.m. ET. Investors can access the earnings report through Amwell's investor relations website, and a live audio webcast of the conference call will be available. A replay of the call will be accessible via webcast on the investor relations website after the event.
Amwell (NYSE: AMWL), fornitore di una piattaforma sanitaria abilitata da tecnologia SaaS, ha annunciato i risultati finanziari per il quarto trimestre e l'intero anno 2024. L'azienda discuterà questi risultati durante una conference call programmata per il 12 febbraio 2025, alle 17:00 ET. Gli investitori possono accedere al rapporto sugli utili attraverso il sito web delle relazioni con gli investitori di Amwell, e sarà disponibile una diretta audio della conference call. Una registrazione della chiamata sarà accessibile tramite webcast sul sito delle relazioni con gli investitori dopo l'evento.
Amwell (NYSE: AMWL), proveedor de una plataforma de atención médica habilitada por tecnología basada en SaaS, ha anunciado sus resultados financieros para el cuarto trimestre y el año completo 2024. La compañía discutirá estos resultados durante una conferencia telefónica programada para el 12 de febrero de 2025, a las 5 p.m. ET. Los inversores pueden acceder al informe de ganancias a través del sitio web de relaciones con inversores de Amwell, y habrá una transmisión en vivo de audio de la conferencia telefónica. Una repetición de la llamada estará disponible a través de webcast en el sitio de relaciones con inversores después del evento.
Amwell (NYSE: AMWL), SaaS 기반의 기술 지원 의료 플랫폼 제공업체,가 2024년 4분기 및 연간 재무 결과를 발표했습니다. 회사는 2025년 2월 12일 오후 5시 ET에 예정된 전화 회의에서 이 결과를 논의할 것입니다. 투자자는 Amwell의 투자자 관계 웹사이트를 통해 수익 보고서를 액세스할 수 있으며, 전화 회의의 실시간 오디오 웹캐스트가 제공될 것입니다. 회의 후 웹캐스트를 통해 회의 녹화본을 액세스할 수 있습니다.
Amwell (NYSE: AMWL), fournisseur d'une plateforme de santé habilitée par une technologie basée sur SaaS, a annoncé ses résultats financiers pour le quatrième trimestre et l'année entière 2024. L'entreprise discutera de ces résultats lors d'une conférence téléphonique prévue le 12 février 2025 à 17h00 ET. Les investisseurs peuvent accéder au rapport de résultats via le site web des relations avec les investisseurs d'Amwell, et un webcast audio en direct de la conférence téléphonique sera disponible. Un enregistrement de l'appel sera accessible par webcast sur le site des relations avec les investisseurs après l'événement.
Amwell (NYSE: AMWL), Anbieter einer technologiegestützten Gesundheitsplattform auf SaaS-Basis, hat seine finanziellen Ergebnisse für das vierte Quartal und das Gesamtjahr 2024 bekannt gegeben. Das Unternehmen wird diese Ergebnisse während einer Telefonkonferenz besprechen, die für den 12. Februar 2025 um 17:00 Uhr ET angesetzt ist. Investoren können den Gewinnbericht über die Investor-Relations-Website von Amwell abrufen, und eine Live-Audioübertragung der Telefonkonferenz wird verfügbar sein. Eine Wiederholung des Anrufs wird nach der Veranstaltung über die Investor-Relations-Website als Webcast zugänglich sein.
- None.
- None.
BOSTON, Feb. 12, 2025 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the fourth quarter and full year ended Dec. 31, 2024. Visit Amwell’s investor relations website at investors.amwell.com to view the fourth quarter and full year 2024 earnings report.
The company will host a conference call to discuss its financial results today at 5 p.m. ET, Feb. 12. The call can be accessed via a live audio webcast at https://edge.media-server.com/mmc/p/zsp4abpw. A replay of the call will be available via webcast shortly after the completion of the call, at investors.amwell.com.
About Amwell
Amwell is a leading hybrid care, delivery enablement platform in the United States and globally, connecting and enabling providers, payers, patients, and innovators to deliver greater access to more affordable, higher quality care. Amwell believes that hybrid care delivery will transform healthcare. We offer a single, comprehensive platform to support all digital health needs from urgent to acute and post-acute care, as well as chronic care management and healthy living. With nearly two decades of experience, Amwell powers the digital care of 50 health plans, which collectively represent more than 80 million covered lives, and many of the nation’s largest health systems. For more information, please visit https://business.amwell.com/. For more information, please visit https://business.amwell.com/.
©2025 American Well Corporation. All rights reserved. Amwell®, SilverCloud®, Amwell Converge™, Carepoint™ and the Amwell Logo are registered trademarks or trademarks of American Well Corporation.
FAQ
When did Amwell (AMWL) release its Q4 2024 earnings?
How can investors access Amwell's (AMWL) Q4 2024 earnings call?
Where can investors find Amwell's (AMWL) Q4 2024 earnings report?
How can investors access the replay of Amwell's (AMWL) Q4 2024 earnings call?
